ALTERATION OF PHOSPHOLIPASE C-DELTA PROTEIN LEVEL AND SPECIFIC ACTIVITY IN ALZHEIMERS-DISEASE

被引：0
|
作者：
SHIMOHAMA, S
FUJIMOTO, S
MATSUSHIMA, H
TAKENAWA, T
TANIGUCHI, T
PERRY, G
WHITEHOUSE, PJ
KIMURA, J
机构：
[1] KYOTO PHARMACEUT UNIV,DEPT BIOCHEM,KYOTO,JAPAN
[2] KYOTO PHARMACEUT UNIV,DEPT NEUROBIOL,KYOTO,JAPAN
[3] UNIV TOKYO,INST MED,DEPT ONCOBIOL,MINATO KU,TOKYO,JAPAN
[4] CASE WESTERN RESERVE UNIV HOSP,INST PATHOL,DIV NEUROPATHOL,CLEVELAND,OH 44106
[5] CASE WESTERN RESERVE UNIV HOSP,DEPT NEUROL,CLEVELAND,OH 44106
来源：
JOURNAL OF NEUROCHEMISTRY | 1995年 / 64卷 / 06期
关键词：
ALZHEIMERS DISEASE; NEUROFIBRILLARY TANGLES; PHOSPHOLIPASE C-DELTA; ANTIBODY; CONCENTRATION; ACTIVITY; INACTIVATION;
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Phosphoinositide-specific phospholipase C (PLC) is a key enzyme in signal transduction. We have previously demonstrated that an antibody to an isozyme of PLC, PLC-delta, produced intense staining of neurofibrillary tangles in the brains of patients with Alzheimer's disease. In the present study, we investigated the protein level and activity of this enzyme in control and Alzheimer brains. Western blot analysis using a specific antibody for PLC-delta showed that the concentration of PLC-delta protein was significantly higher in the cytosolic fraction of Alzheimer's disease cortical tissue than in control brains. The activity of PLC-delta, which hydrolyzes phosphatidylinositol, was also investigated, and we found that PLC-delta activity was not significantly different in the Alzheimer and control cytosolic fractions. These results indicate that the specific activity of PLC-delta is decreased in Alzheimer brains and suggest that inactivation of PLC-delta might be related to the pathophysiology of this disease.
引用
收藏
页码：2629 / 2634
页数：6
相关论文
共 50 条
  • [21] AMYLOID PROTEIN AND EARLY ONSET FAMILIAL ALZHEIMERS-DISEASE
    CHARTIERHARLIN, MC
    BULLETIN DE L INSTITUT PASTEUR, 1991, 89 (03): : 159 - 186
  • [22] PROCESSING AND SECRETION OF ALZHEIMERS-DISEASE AMYLOID PRECURSOR PROTEIN
    KINBARA, K
    KITAGAKI, H
    KINOUCHI, T
    OKANO, M
    SORIMACHI, H
    ISHIURA, S
    SUZUKI, K
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 174 (03) : 209 - 216
  • [23] COMPETITIVE ELISA FOR THE MEASUREMENT OF TAU PROTEIN IN ALZHEIMERS-DISEASE
    HARRINGTON, CR
    EDWARDS, PC
    WISCHIK, CM
    JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 134 (02) : 261 - 271
  • [24] THE PROTEIN TYROSINE KINASE, FYN, IN ALZHEIMERS-DISEASE PATHOLOGY
    SHIRAZI, SK
    WOOD, JG
    NEUROREPORT, 1993, 4 (04) : 435 - 437
  • [25] BETA-AMYLOID, PROTEIN PROCESSING AND ALZHEIMERS-DISEASE
    HAASS, C
    HUNG, AY
    CITRON, M
    TEPLOW, DB
    SELKOE, DJ
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1995, 45-1 (3A): : 398 - 402
  • [26] FUNCTIONAL-STUDIES OF ALZHEIMERS-DISEASE TAU PROTEIN
    LU, Q
    WOOD, JG
    JOURNAL OF NEUROSCIENCE, 1993, 13 (02) : 508 - 515
  • [27] CIRCADIAN LOCOMOTOR-ACTIVITY RHYTHMS IN ALZHEIMERS-DISEASE
    SATLIN, A
    TEICHER, MH
    LIEBERMAN, HR
    BALDESSARINI, RJ
    VOLICER, L
    RHEAUME, Y
    NEUROPSYCHOPHARMACOLOGY, 1991, 5 (02) : 115 - 126
  • [28] SCG10, A NEURON-SPECIFIC GROWTH-ASSOCIATED PROTEIN IN ALZHEIMERS-DISEASE
    OKAZAKI, T
    WANG, H
    MASLIAH, E
    CAO, M
    JOHNSON, SA
    SUNDSMO, M
    SAITOH, T
    MORI, N
    NEUROBIOLOGY OF AGING, 1995, 16 (06) : 883 - 894
  • [29] PRESERVATION OF G(I)-PROTEIN INHIBITED ADENYLYL CYCLASE ACTIVITY IN THE BRAINS OF PATIENTS WITH ALZHEIMERS-DISEASE
    COWBURN, RF
    ONEILL, C
    RAVID, R
    WINBLAD, B
    FOWLER, CJ
    NEUROSCIENCE LETTERS, 1992, 141 (01) : 16 - 20
  • [30] ALTERATION IN THE PATTERN OF NERVE-TERMINAL PROTEIN IMMUNOREACTIVITY IN THE PERFORANT PATHWAY IN ALZHEIMERS-DISEASE AND IN RATS AFTER ENTORHINAL LESIONS
    CABALKA, LM
    HYMAN, BT
    GOODLETT, CR
    RITCHIE, TC
    VANHOESEN, GW
    NEUROBIOLOGY OF AGING, 1992, 13 (02) : 283 - 291
12345